About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Search for Therapeutic Synergy in Primary Effusion Lymphoma

by Bidita Debnath on May 6, 2013 at 10:25 PM
Font : A-A+

 Scientists Search for Therapeutic Synergy in Primary Effusion Lymphoma

A rare and fatal form of aggressive B-cell lymphoma is Primary effusion lymphoma (PEL), which is caused by Kaposi's sarcoma-associated herpesvirus (KSHV).

The disease most commonly occurs in immunocompromised patients, such as those with HIV and the elderly. Because current treatment options are not effective, there is a great need for new PEL therapies.

Advertisement

In this issue of the Journal of Clinical Investigation, Juan Carlos Ramos and colleagues at the University of Miami used an immunocompromised mouse model of PEL to determine the efficacy of Bortezomib/Vorinostat combination therapy, two drugs that are currently being used to treat multiple myeloma and cutaneous T cell lymphoma, respectively. They found that this treatment combination reactivated virus-induced cell lysis and induced PEL cell death, increasing the lifespan of mice with PEL tumors.

These findings indicate that this drug combination could potentially be beneficial in immunocompromised patients with KSHV-associated malignancies.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chronic Lymphocytic Leukemia AIDS-HIV-Cancer Bone Marrow Transplantation 

Recommended Reading
Patient Survival in Non-Hodgkins Lymphoma may be Predicted by Epigenomic Abnormalities
Abnormal changes in the epigenetic mixing board can change the expression of genes in cancer, a ......
For Treating Relapsed Lymphomas, High-dose Vorinostat Effective
Cancer patients whose aggressive lymphomas have relapsed or failed to respond to the current ......
Targeted Combinational Therapy For Deadly Lymphoma
US researchers are suggesting a new targeted combinational therapy to fight Diffuse large B-cell ......
Burkitt’s Lymphoma
Burkitt's lymphoma is a rare type of non-hodgkin's lymphoma that commonly affects children. It ......
AIDS-HIV-Cancer
AIDS defining malignancies are cancers that occur in patients with AIDS due to their low immunity....
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is consider...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use